Annual Dialysis Data Report 2015, JSDT Renal Data Registry

Abstract

AbstractsThe annual survey of Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) was conducted for 4380 dialysis facilities at the end of 2015, among which 4321 facilities (98.7%) responded. The response rate of the 2015 survey was comparable with the past, even though it was the first year after the new anonymization method. The number of chronic dialysis patients in Japan continues to increase every year; it has reached 324,986 at the end of 2015. The mean age was 67.86 years. At the end of 2015, the prevalence rate was 2592 patients per million population. Diabetic nephropathy was the most common primary disease among the prevalent dialysis patients (38.4%), followed by chronic glomerulonephritis (29.8%) and nephrosclerosis (9.5%). The rate of diabetic nephropathy and nephrosclerosis has been increasing year by year, whereas that of chronic glomerulonephritis was declining. The number of incident dialysis patients during 2015 was 39,462; it has remained stable since 2008. The average age was 69.20 years, and diabetic nephropathy (43.7%) was the most common cause in the incident dialysis patients. These patients caused by diabetes did not change in number for the last several years. Meanwhile, 31,608 patients died in 2015; the crude mortality rate was 9.6%. The patients treated by hemodiafiltration (HDF) have been increasing rapidly from the revision of medical reimbursement for HDF therapy in 2012. It has attained 53,776 patients at the end of 2015, which were 10,493 greater than that in 2014. In particular, the number of online HDF patients increased about ten times 2012. The number of peritoneal dialysis (PD) patients was 9322 in 2015, which was slightly increased than 2014. Twenty percent of PD patients treated in the combination of hemodialysis (HD) or HDF therapy. Five hundred seventy-two patients underwent home HD therapy at the end of 2015; it increased by 43 from 2014. Further JRDR data analyses could clarify the relationships between various dialysis modalities, patient care, and clinical outcomes; furthermore, it could also make it possible to establish clinical practice guidelines or medical reimbursement revisions based on the evidence. Japanese Society for Dialysis Therapy (JSDT) has conducted a survey (JSDT Renal Data Registry: JRDR) on the status of chronic dialysis therapy in Japan at the end of every year since 1968, covering almost all dialysis facilities throughout the country [1,2]. Despite the fact that this survey is conducted without providing any compensation to participating facilities, its response rate represents a largely complete and unbiased survey of the status of chronic dialysis in Japan, making it quite rare in the world. In publishing our results, we would like to take this opportunity to express our sincere gratitude to everyone at the participating dialysis facilities for taking part in the survey in addition to their routine clinical practice.JRDR had previously featured two types of reports: prompt (unfixed) data reported at the annual meeting held every J...

Clinical practice guideline for renal rehabilitation: systematic reviews and recommendations of exercise therapies in patients with kidney diseases

“…Dialysis therapy can be either hemodialysis or peritoneal dialysis, but 97% of patients in Japan are receiving hemodialysis. At the end of 2015, the mean age of patients on dialysis was 67.9 years, and a prominent [37]. With aging of dialysis patients, frail patients are increasing.…”

Annual Dialysis Data Report 2016, JSDT Renal Data Registry

“…In contrast, countries other than Japan have been requesting that the results of the JRDR be published in a form that people worldwide may easily use. Because of such circumstances, the English-language annual report has been published in Renal Replacement Therapy (RRT) since the report for 2014 [7,8]. We expect that the PDF of the English-language annual report, an English translation of the figures as a PowerPoint file, and an Excel file of the tables, will be available to the world from the English-language website of the JSDT.…”

The use of a tunneled permanent catheter as temporary vascular access in arteriovenous graft patients for long-term patency

“…Generally, the preferred route of vascular access in chronic kidney disease patients is an arteriovenous fistula (AVF) rather than grafts. However, approximately 7% of 300,000 Japanese hemodialysis (HD) patients continue to dialyze with grafts [1,2]. In patients who have arteriovenous grafts (AVGs), complications such as thrombosis, hemorrhaging, and infection are common, resulting in lower graft patency [3,4].…”